These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1629903)

  • 21. Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods.
    Su PA; Wu LT; Cheng KC; Ko WC; Chuang YC; Yu WL
    J Microbiol Immunol Infect; 2010 Feb; 43(1):26-34. PubMed ID: 20434120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Variation in transfer resistance to cefotaxime, ceftazidime and aztreonam in strains of Acinetobacter sp., Enterobacter sp. and Citrobacter sp. isolated from the same university hospitals].
    Babálová M; Krălíková K; Krcméry V; Kubonová K
    Cas Lek Cesk; 1996 Mar; 135(6):181-4. PubMed ID: 8681362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nosocomial outbreak due to extended-spectrum-beta-lactamase- producing Enterobacter cloacae in a cardiothoracic intensive care unit.
    Manzur A; Tubau F; Pujol M; Calatayud L; Dominguez MA; Peña C; Sora M; Gudiol F; Ariza J
    J Clin Microbiol; 2007 Aug; 45(8):2365-9. PubMed ID: 17581932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The expression of AmpC and extended-spectrum beta-lactamases among clinical isolates of enterobacter cloacae and its impact on antibiotics susceptibility].
    She D; Liu Y
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1355-8. PubMed ID: 12509943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital.
    Wu JJ; Ko WC; Tsai SH; Yan JJ
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1223-7. PubMed ID: 17242140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility patterns to extended-spectrum cephalosporins among Enterobacteriaceae harbouring extended-spectrum β-lactamases using the updated Clinical and Laboratory Standards Institute interpretive criteria.
    Kristo I; Pitiriga V; Poulou A; Zarkotou O; Kimouli M; Pournaras S; Tsakris A
    Int J Antimicrob Agents; 2013 Apr; 41(4):383-7. PubMed ID: 23375981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of resistance due to inducible beta-lactamase in Enterobacter aerogenes and Enterobacter cloacae.
    Huber TW; Thomas JS
    J Clin Microbiol; 1994 Oct; 32(10):2481-6. PubMed ID: 7814486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First report of CTX-M-9 in a clinical isolate of Enterobacter cloacae in a Tunisian hospital.
    Bourouis A; Dubois V; Coulange L; André C; Bejhadj C; Ben Moussa M; Quentin C; Belhadj O
    Pathol Biol (Paris); 2011 Aug; 59(4):187-91. PubMed ID: 19481370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae.
    Rasmussen BA; Bush K; Keeney D; Yang Y; Hare R; O'Gara C; Medeiros AA
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2080-6. PubMed ID: 8878585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of resistance to ceftazidime during therapy for Enterobacter cloacae infections.
    Quinn JP; DiVincenzo CA; Foster J
    J Infect Dis; 1987 May; 155(5):942-7. PubMed ID: 3549922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic organization of plasmid-mediated Qnr determinants in cefotaxime-resistant Enterobacter cloacae isolates in Korea.
    Kim YS; Kim ES; Jeong JY
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):318-21. PubMed ID: 20846811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissemination of transferable CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
    Jeong SH; Bae IK; Kwon SB; Lee JH; Song JS; Jung HI; Sung KH; Jang SJ; Lee SH
    J Appl Microbiol; 2005; 98(4):921-7. PubMed ID: 15752339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance characteristics of blood culture isolates of Enterobacter cloacae with special reference to beta-lactamases and relation to preceding antimicrobial therapy.
    Weischer M; Schumacher H; Kolmos HJ
    APMIS; 1994 May; 102(5):356-66. PubMed ID: 8024737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of ampicillin versus cefuroxime on the emergence of beta-lactam resistance in faecal Enterobacter cloacae isolates from neonates.
    Burman LG; Berglund B; Huovinen P; Tullus K
    J Antimicrob Chemother; 1993 Jan; 31(1):111-6. PubMed ID: 8444655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of IncHI2 plasmids harbouring blaVIM-1, blaCTX-M-9, aac(6')-Ib and qnrA genes in the spread of multiresistant Enterobacter cloacae and Klebsiella pneumoniae strains in different units at Hospital Vall d'Hebron, Barcelona, Spain.
    Coelho A; Piedra-Carrasco N; Bartolomé R; Quintero-Zarate JN; Larrosa N; Cornejo-Sánchez T; Prats G; Garcillán-Barcia MP; de la Cruz F; González-Lopéz JJ
    Int J Antimicrob Agents; 2012 Jun; 39(6):514-7. PubMed ID: 22481058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 and ArmA 16S rRNA methylase conferring high-level aminoglycoside resistance in carbapenem-resistant Enterobacter cloacae in China.
    Wu Q; Liu Q; Han L; Sun J; Ni Y
    Diagn Microbiol Infect Dis; 2010 Mar; 66(3):326-8. PubMed ID: 19903584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of tazobactam on the frequency of the emergence of resistant strains from Enterobacter cloacae, Citrobacter freundii, and Proteus vulgaris (beta-lactamase derepressed mutants).
    Higashitani F; Nishida K; Hyodo A; Inoue M
    J Antibiot (Tokyo); 1995 Sep; 48(9):1027-33. PubMed ID: 7592048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of SHV-12 extended spectrum beta-lactamase among clinical isolates of Enterobacter cloacae in Tunisia.
    Lahlaoui H; Anis BH; Mohamed K; Mohamed BM
    Microb Pathog; 2012 Aug; 53(2):64-5. PubMed ID: 22543154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic and biochemical characterisation of CTX-M-37 extended-spectrum β-lactamase from an Enterobacter cloacae clinical isolate from Mongolia.
    Lee K; Yong D; Jeong SH; Tulgaa K; Docquier JD; Rossolini GM; Chong Y
    J Glob Antimicrob Resist; 2017 Sep; 10():3-7. PubMed ID: 28587869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.